Infections in patients undergoing targeted antineoplastic therapy
Home Diseases and Conditions Overview In recent decades, targeted antineoplastic therapy, which includes small molecule inhibitors, has developed as a complement or alternative to chemotherapy for cancer. Biological therapy, in turn, includes monoclonal antibodies, immune checkpoint inhibitors, CAR T-lymphocyte cell therapy, oncolytic virus inoculation, and anti-cancer vaccines. In our time, modern cancer treatments that are […]
